TnT Fast Test Kit

 (Immunofluorescence Assay)

Intended Use

TnT Fast Test Kit (Immunofluorescence Assay) is intended for in vitro quantitative determination of TnT in serum, plasma or whole blood samples. The test is indicated to be used as an auxiliary means for the early screening of acute myocardial infarction (AMI), heart failure, unstable angina pectoris, myocarditis and other myocardial injuries, it can also be used for the assessment of prognosis and risk stratification of acute pulmonary embolism and the monitoring

of myocardial injury in thoracic surgery.

About TnT

Troponin T (TNT) is a substance that regulates the contraction of striated muscles. Although the function of TNT is the same in all rhabdom muscles, the myocardial production of TNT (TNT, molecular weight 39.7kD) is not the same as that of skeletal muscle TNT. Because of the high tissue specificity, cardiac troponin T (TnT) is a specific and highly sensitive marker of myocardial injury. At present, the clinical laboratory diagnostic methods of TNT include immune enhanced turbidimetry, colloidal gold assay, enzyme linked immunoassay and chemiluminescence.

Contents

1. For Getein1100

Package specifications: 25 tests/box, 10 tests/box

1) Getein TnT test card in a sealed pouch with desiccant

2) Disposable pipet

3) Whole blood buffer: 1 bottle/box

4) User manual: 1 piece/box

5) SD card: 1 piece/box

2. For Getein1600

Package specifications: 2×24 tests/kit, 2×48 tests/kit

1) Sealed cartridge with 24/48 Getein TnT test cards

2) User manual: 1 piece/box

Materials required for Getein1600:

1) Sample diluent: 1 bottle/box

2) Box with pipette tips: 1 piece/box

3) Mixing plate: 1 piece/box

Note: Do not mix or interchange different batches of kits.

Specifications

Applicable Device

Getein1100 Immunofluorescence Quantitative Analyzer

Getein1600 Immunofluorescence Quantitative Analyzer

Clinical Application

1. As an aid in the early detection and screening of acute myocardial infarction (AMI), heart failure,unstable angina pectoris, myocarditis and other myocardial injuries.

2. As an aid in the assessment of prognosis and risk stratification of acute pulmonary embolism, and monitoring of myocardial injuries in thoracic surgery.